X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
medicine, general & internal (59) 59
index medicus (55) 55
randomized controlled trials as topic (55) 55
adult (44) 44
child (33) 33
asthma - drug therapy (30) 30
chronic disease (19) 19
administration, inhalation (18) 18
formoterol fumarate (17) 17
asthma [drug therapy] (16) 16
review literature as topic (16) 16
adolescent (14) 14
albuterol - analogs & derivatives (14) 14
anti-asthmatic agents - administration & dosage (14) 14
double-blind (13) 13
salmeterol xinafoate (13) 13
fluticasone (12) 12
quality-of-life (12) 12
article (11) 11
studies (11) 11
ethanolamines - administration & dosage (10) 10
health care sciences & services (10) 10
public, environmental & occupational health (10) 10
systematic review (10) 10
adrenal cortex hormones - administration & dosage (9) 9
adrenergic beta-agonists - adverse effects (9) 9
anti-asthmatic agents - adverse effects (9) 9
ethanolamines - adverse effects (9) 9
metered-dose inhaler (9) 9
adrenergic beta-agonists - administration & dosage (8) 8
albuterol - administration & dosage (8) 8
albuterol - adverse effects (8) 8
androstadienes - administration & dosage (8) 8
anti-asthmatic agents [administration & dosage] (8) 8
asthma - mortality (8) 8
bias (8) 8
budesonide - administration & dosage (8) 8
drug therapy, combination (8) 8
quality (8) 8
research (8) 8
bronchodilator agents - therapeutic use (7) 7
cost-effectiveness (7) 7
drug combinations (7) 7
epidemiology (7) 7
evidence-based medicine (7) 7
guidelines (7) 7
meta-analysis (7) 7
to-moderate asthma (7) 7
adrenal cortex hormones [administration & dosage] (6) 6
adrenergic beta-agonists - therapeutic use (6) 6
bronchodilator agents - administration & dosage (6) 6
bronchodilator agents - adverse effects (6) 6
bronchodilator agents [administration & dosage] (6) 6
drug therapy (6) 6
dry powder inhaler (6) 6
female (6) 6
internal medicine (6) 6
mortality (6) 6
nebulizers and vaporizers (6) 6
randomized controlled-trial (6) 6
reviews (6) 6
salmeterol/fluticasone propionate (6) 6
adrenal cortex hormones - adverse effects (5) 5
adrenergic beta-agonists [administration & dosage] (5) 5
adrenergic beta-agonists [therapeutic use] (5) 5
aged (5) 5
budesonide/formoterol maintenance (5) 5
clinical-trials (5) 5
combination (5) 5
efficacy (5) 5
ethanolamines [administration & dosage] (5) 5
exhaled nitric-oxide (5) 5
fluticasone propionate (5) 5
male (5) 5
medicine general & introductory medical sciences (5) 5
prevention (5) 5
respiratory system (5) 5
systematic reviews (5) 5
therapy (5) 5
a h3n2 (4) 4
abridged index medicus (4) 4
access to information (4) 4
adrenal cortex hormones - therapeutic use (4) 4
adrenal cortex hormones [therapeutic use] (4) 4
albuterol - therapeutic use (4) 4
androstadienes - adverse effects (4) 4
androstadienes [administration & dosage] (4) 4
anti-asthmatic agents - therapeutic use (4) 4
asthma (4) 4
asthma - prevention & control (4) 4
asthma [drug therapy; mortality] (4) 4
budesonide - adverse effects (4) 4
budesonide [administration & dosage] (4) 4
clinical trials (4) 4
decision making (4) 4
health personnel (4) 4
infections (4) 4
influenza vaccines - administration & dosage (4) 4
influenza, human - prevention & control (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2012, Issue 9, p. CD006829
Background Both inhaled steroids (ICS) and long-acting beta(2)-agonists (LABA) are used in the management of chronic obstructive pulmonary disease (COPD). This... 
Adrenal Cortex Hormones [administration & dosage; adverse effects] | COST-EFFECTIVENESS | Adrenergic beta-Agonists [administration & dosage; adverse effects] | CLINICAL-TRIAL | Humans | FLUTICASONE PROPIONATE/SALMETEROL 250/50 | SALMETEROL/FLUTICASONE PROPIONATE | COPD EXACERBATIONS | LUNG-FUNCTION | RANDOMIZED CONTROLLED-TRIAL | Pneumonia [chemically induced] | Randomized Controlled Trials as Topic | SALMETEROL | Bronchodilator Agents [administration & dosage; adverse effects] | Pulmonary Disease, Chronic Obstructive [drug therapy; mortality] | MEDICINE, GENERAL & INTERNAL | METERED-DOSE INHALER | Quality of Life | Adult | Drug Therapy, Combination | 50 MU-G | Drug Combinations | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - mortality | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Fluticasone | Ethanolamines - administration & dosage | Pneumonia - chemically induced | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Albuterol - analogs & derivatives | Adrenal Cortex Hormones - adverse effects | Drug Therapy, Combination - methods | Androstadienes - administration & dosage | Budesonide - adverse effects | Budesonide - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2009, Issue 2
Journal Article
Journal Article